Tag: Complement system

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Complement system

Hematologic Disorders and Therapeutic Complement Inhibition - Physician's Weekly

Added to Collection on: 2022-07-14 18:53:53

Tags for this article:

Complement system
Medical specialties
Organ systems
Immunology
Acquired hemolytic anemia
Monoclonal antibodies
Orphan drugs
Rare diseases
Factor D
Eculizumab
Paroxysmal nocturnal hemoglobinuria
Classical complement pathway

Click the tags to see associated articles and topics

View Article Details
Gemini (GMTX) Drops 5.99% for July 19 | Equities News

Added to Collection on: 2022-07-20 05:10:39

Tags for this article:

Complement system
Factor H
Project Gemini
Gemini
Equities.com Inc.

Click the tags to see associated articles and topics

View Article Details
Transcenta Received IND Clearance from FDA for Its Best-In-Class MASP2 Targeting ...

Added to Collection on: 2022-10-05 08:02:07

Tags for this article:

Medical specialties
Branches of biology
Complement system
Medicine
Immune system
Immunology
Kidney diseases
Glycoproteins
Mannose-binding protein-associated serine protease
Lectin pathway
MASP2
Mannan-binding lectin
China
Transcenta Holding Limited

Click the tags to see associated articles and topics

View Article Details
Frontrunner in Therapies for Complement-Mediated Diseases - BioPharm International

Added to Collection on: 2023-09-21 20:09:27

Tags for this article:

Eye diseases
Complement system
Geographic atrophy
Macular degeneration
Factor H
National Eye Institute
AMD
Stem cells
CTX

Click the tags to see associated articles and topics

View Article Details
Molecular characterization and functional implications on mouse peripheral blood ...

Added to Collection on: 2023-10-06 17:58:08

Tags for this article:

Complement factor I
Complement system
Apoptosis
Peripheral blood mononuclear cell
United States
China

Click the tags to see associated articles and topics

View Article Details
Paroxysmal Nocturnal Hemoglobinuria Market is Expected - openPR.com

Added to Collection on: 2024-05-01 15:57:31

Tags for this article:

Immunosuppressants
Orphan drugs
Hematology
Monoclonal antibodies
Complement system
Pegcetacoplan
Alexion Pharmaceuticals
PNH
Danicopan
Paroxysmal nocturnal hemoglobinuria
Crovalimab
Eculizumab

Click the tags to see associated articles and topics

View Article Details
EU CHMP issues negative opinion on Apellis MAA application for pegcetacoplan (Syfovre ...

Added to Collection on: 2024-07-02 21:13:55

Tags for this article:

Orphan drugs
Immunosuppressants
Complement system
Pegcetacoplan
Geographic atrophy
European Medicines Agency
Committee for Medicinal Products for Human Use
Marketing authorisation
Apellis Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Atypical Hemolytic Uremic Syndrome Treatment Market 2034: - openPR.com

Added to Collection on: 2024-08-26 15:17:01

Tags for this article:

Blood disorders
Monoclonal antibodies
Acquired hemolytic anemia
Nephrology
Ahus
Complement system
Atypical hemolytic uremic syndrome
Alexion Pharmaceuticals
Hemolytic–uremic syndrome
Hemolysis
Complement factor I
Eculizumab

Click the tags to see associated articles and topics

View Article Details
NICE recommendation for new Alexion PNH treatment - PharmaTimes

Added to Collection on: 2024-10-24 15:34:41

Tags for this article:

Orphan drugs
Monoclonal antibodies
Immunosuppressants
Rare diseases
Complement system
Ravulizumab
Paroxysmal nocturnal hemoglobinuria
Eculizumab
Hemolysis
Hemolytic anemia
Factor D
AstraZeneca
Alexion

Click the tags to see associated articles and topics

View Article Details
Ocugen announces positive preliminary data from OCU410 Phase 1 clinical trial for ...

Added to Collection on: 2024-11-19 19:09:24

Tags for this article:

Eye diseases
Gene delivery
Medical genetics
Molecular biology
Complement system
Pegcetacoplan
Geographic atrophy
Macular degeneration
Stargardt disease
Gene therapy
Ocugen Inc.

Click the tags to see associated articles and topics

View Article Details